The prevalence of allergic diseases is increasing sharply in both developed and developing countries. These diseases include: asthma; rhinitis; anaphylaxis; drug, food, and insect allergy; eczema; and urticaria (hives) and angioedema. Allergic asthma and rhino-conjunctivitis are the most common. Asthma incidence is rising, affecting some 300 million people worldwide. Allergic rhinitis (AR) affects an estimated 10-30% of the world’s population, with prevalence rates also increasing worldwide. Dr Juan Gispert, Senior Medical Director and Head of Quintiles’ Allergy and Respiratory Center of Excellence, provides an overview of allergy therapies.
https://international-pharma.com/wp-content/uploads/2015/06/Allergy-Therapies…pdf.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Allergy Therapies: Increasing the Probability of Clinical Development Success -Dr Juan Gispert, Quintiles
